介入肺脏病学发展现状与展望

Current status and prospects of interventional pulmonology in China

介入肺脏病学是一门涉及呼吸病侵入性诊断和治疗操作的新兴学科,其专业领域涉及各种呼吸系统疾病的诊断和分期,侧重于胸部肿瘤,良、恶性气道狭窄,胸膜疾病及肺血管性病变的治疗。目前,我国的介入肺脏病学事业呈现良好的发展态势,形成了一定的专业特色。肺癌、慢性阻塞性肺疾病(COPD)和哮喘等呼吸系统常见病和多发病今后将会成为介入肺脏病学研究和关注的重点。

Interventional pulmonology is a newly developed medical discipline devoted to the performance of diagnosis and invasive therapy of respiratory diseases.The professional field of this discipline refers to diagnosis and staging of respiratory diseases,and focuses on treatment of pulmonary tumors,benign or malignant airway stenosis,pleural disease and pulmonary vascular diseases.So far,huge strides have been made in interventional pulmonology,and therefore some distinct features have been developed in China.Prevalent and common diseases,such as lung cancer,chronic obstructive pulmonary disease（COPD） and asthma,will hereafter be the foci of interventional pulmonary in China.